Levobunolol
From Self-sufficiency
File:Levobunolol structural formulae.png | |
Systematic (IUPAC) name | |
---|---|
(S)-5-{[3-(tert-butylamino)-2-hydroxypropyl]oxy}-3,4-dihydronaphthalen-1(2H)-one | |
Clinical data | |
Pregnancy category |
|
Routes of administration | Topical (eye drops) |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Biological half-life | 20 hours |
Identifiers | |
CAS Number | 47141-42-4 |
ATC code | S01ED03 (WHO) |
PubChem | CID 39468 |
DrugBank | APRD00165 |
Chemical data | |
Formula | C17H25NO3 |
Molar mass | 291.385 g/mol[[Script error: No such module "String".]] |
Script error: No such module "collapsible list". | |
(verify) |
Levobunolol (AK-Beta, Liquifilm, Betegan) is a non-selective beta blocker. It is used topically to manage glaucoma.
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
External links
- Ishibashi T, Yokoi N, Kinoshita S (2003). "Comparison of the effects of topical levobunolol and timolol solution on the human ocular surface". Cornea. 22 (8): 709–15. doi:10.1097/00003226-200311000-00001. PMID 14576520.
- Ogasawara H, Yoshida A, Fujio N, Konno S, Ishiko S (1999). "[Effect of topical levobunolol on retinal, optic nerve head, and choroidal circulation in normal volunteers]". Nippon Ganka Gakkai Zasshi. 103 (7): 544–50. PMID 10443129.
- Leung M, Grunwald J (1997). "Short-term effects of topical levobunolol on the human retinal circulation". Eye. 11 ( Pt 3): 371–6. PMID 9373479.
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- CS1 maint: Multiple names: authors list
- Beta blockers
- Ketones
- Phenol ethers
- Alcohols
- Tetralines
- 2Fix